古汉医药江琎：2026年目标实现超30个品种恢复生产 打好发展基础

Core Viewpoint - Guhanshan Pharmaceutical is leveraging its partnership with Hengchang Pharmaceutical Group to expand its market reach and enhance product competitiveness, particularly focusing on its flagship product, Guhanshan Health Essence [1][2]. Group 1: Company Overview - Guhanshan Pharmaceutical, established in 1996, is the first pharmaceutical company listed in Hunan Province, with its core product, Guhanshan Health Essence, based on a 2200-year-old ancient health formula [1]. - The company has achieved remarkable sales performance, with Guhanshan Health Essence reportedly selling approximately 4 units per second in the Hunan OTC retail market [1]. Group 2: Strategic Developments - The company has undergone a control change in 2025, with Jiang Jin becoming the new actual controller, and has formed a strategic partnership with Hengchang Pharmaceutical Group, leading to a rebranding from "Qidi Pharmaceutical" to "Guhanshan Pharmaceutical" [1]. - Guhanshan Pharmaceutical aims to optimize its existing product lines and production capacity, with plans to restore production for over 30 varieties this year, focusing on achieving positive cash flow [2]. Group 3: Market Expansion and Collaboration - Hengchang Pharmaceutical Group currently serves over 200,000 member pharmacies and clinics, generating nearly 4 billion yuan in annual sales, which positions it as a significant partner for Guhanshan Pharmaceutical [2]. - The collaboration is expected to enhance the operational capabilities of both companies, creating a "front store and back factory" ecosystem that supports the growth of small and medium-sized pharmacies [2]. Group 4: Future Growth Strategies - Guhanshan Pharmaceutical plans to build a product matrix centered around Guhanshan Health Essence, while also expanding into chemical drugs and health food sectors [3]. - The company is focusing on integrating cultural tourism with traditional Chinese medicine and promoting intelligent, flexible production methods [3].